Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple MyelomaXiuli Wang, Miriam Walter, Ryan Urak, et al.Nature Medicine|January 23, 2023
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim resultsSham Mailankody, Jeffrey V Matous, Saurabh Chhabra, et al.American Journal of Hematology|September 5, 2023
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphomaShin Yeu Ong, Stacy Pak, Matthew Mei, et al.Leukemia & Lymphoma|April 10, 2020
Repurposing leflunomide for relapsed/refractory multiple myeloma: a phase 1 studyMichael Rosenzweig, Joycelynne Palmer, Ni-Chun Tsai, et al.British Journal of Haematology|June 26, 2018
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myelomaPaul G Richardson, Craig C Hofmeister, Cara A Rosenbaum, et al.Transplantation and Cellular Therapy|January 21, 2023
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution ExperienceTaxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myelomaFiroozeh Sahebi, Paul H Frankel, Len Farol, et al.Ejhaem|August 21, 2023
Haploidentical hematopoietic cell transplant recipient presents with late-onset Epstein Barr virus-associated posttransplant lymphoproliferative disorderAdam Braun, Lawrence Liu, Monzr M Al Malki, et al.Cancer Medicine|April 21, 2023
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experienceIdoroenyi Amanam, Janny Yao, Alfredo Puing, et al.Case Reports in Psychiatry|September 19, 2019
Social and Cultural Factors Leading to Suicide Attempt via Organophosphate Poisoning in NepalChristine Licata, Lawrence Liu, Dale Mole, et al.Pageof 9